A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Clinical trial NCT01725555 · COMPLETED

Trial details

NCT number: NCT01725555
Sponsor: Axelar AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Hematological Malignancies

Start date: 2012-10-01
Primary completion: 2013-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.